Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SIOUX FALLS, S.D., Nov. 20, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel...
15.11.2023 - Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system ...
Redx Pharma will admit £14m new shares to AIM tomorrow as selective DDR1 inhibitor, RXC009, shows positive early signs.